InfuSystem Holdings, Inc. (NYSE:INFU – Get Free Report) has been given an average recommendation of “Buy” by the five ratings firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating, two have assigned a buy rating and two have assigned a strong buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $15.00.
Separately, Roth Mkm reiterated a “buy” rating and issued a $15.00 price objective (up from $14.00) on shares of InfuSystem in a report on Tuesday.
Check Out Our Latest Research Report on InfuSystem
InfuSystem Price Performance
Institutional Trading of InfuSystem
Several hedge funds have recently made changes to their positions in INFU. Geode Capital Management LLC grew its holdings in shares of InfuSystem by 0.8% in the fourth quarter. Geode Capital Management LLC now owns 218,123 shares of the company’s stock valued at $1,958,000 after purchasing an additional 1,831 shares in the last quarter. HighTower Advisors LLC boosted its position in InfuSystem by 13.8% in the 4th quarter. HighTower Advisors LLC now owns 21,061 shares of the company’s stock valued at $189,000 after buying an additional 2,561 shares during the period. Integrated Quantitative Investments LLC grew its stake in shares of InfuSystem by 6.9% in the fourth quarter. Integrated Quantitative Investments LLC now owns 41,484 shares of the company’s stock worth $372,000 after acquiring an additional 2,684 shares in the last quarter. Dynamic Technology Lab Private Ltd grew its stake in shares of InfuSystem by 25.8% in the fourth quarter. Dynamic Technology Lab Private Ltd now owns 13,724 shares of the company’s stock worth $123,000 after acquiring an additional 2,811 shares in the last quarter. Finally, Bank of America Corp DE increased its position in shares of InfuSystem by 19.4% during the second quarter. Bank of America Corp DE now owns 17,994 shares of the company’s stock worth $112,000 after acquiring an additional 2,924 shares during the period. Institutional investors and hedge funds own 71.13% of the company’s stock.
About InfuSystem
InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.
In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.
Further Reading
- Five stocks we like better than InfuSystem
- America’s 1776 happening again
- Buy this stock tomorrow?
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- This makes me furious
- Elon Musk’s New 1,000X Opportunity
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.
